A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
about
Mechanisms of cellular invasion by intracellular parasitesMalaria vaccine clinical trials: what's on the horizonRational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.Synthetic biology for translational research.Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccinePlasmodium vivax malaria vaccines: why are we where we are?Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat regionAntibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein.Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant ChimeraRationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivaxProtective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccinePlasmodium vivax: who cares?Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea.Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin.Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis.Vaccines against Plasmodium vivax: a research challenge.Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion.Immunogenicity of a multi-epitope DNA vaccine against hantavirus.Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
P2860
Q27010243-B40E515E-A407-4D0E-9C38-BC1A74586F73Q28083110-C8CEDA59-5D76-42AF-B48A-D6718A45C5E2Q33572458-B10552F5-768A-4BEF-8E9C-A003C6051BF6Q33617694-A95B3368-030F-42C8-9D6F-A0576266B359Q34073961-482C61EF-9D24-4445-88EC-6139C4EF16B2Q34157315-24D88D3A-4717-470E-8B56-E3F1FFE91938Q34170071-1AB550DF-50C7-4519-A2D5-ADFA6F7E63F5Q34350954-3B698FA1-50D7-4C17-A435-C038D1163A4DQ34546220-FC882A9E-B66E-4DCC-B97A-2F5BD30CE074Q34802680-2B907E28-7022-460F-A165-12DC32397FA8Q35709003-CF343790-0E72-46E5-9D63-8779D9A91C65Q35937418-92401CDF-DDF3-4CF1-8BED-7174478A5318Q35947469-161366A1-5707-419B-98A5-0551623E8C0AQ36247474-3213A919-7720-4ABF-AEB7-D9A4DBE94D65Q36353548-92159D7E-BB71-4699-B6E4-8B66B9DFEEEAQ37018632-BBC64BD0-9718-47AF-8C2C-7F669BE91861Q37036065-62B23DAD-404D-46DE-9BE0-EBC2C903A3D7Q37058586-9633DD9E-A4EE-428E-A24B-69970D1FBCF2Q37357825-D471BA99-A2E8-43DF-A977-5B3DB531EC4DQ37469633-0AFA0EE6-5DDF-4904-9633-BE0FBA01526DQ37546314-3570291B-531B-4553-8BE6-C462655544ABQ37638131-579C0658-B7EF-48D1-AEEE-8DF3F90B75A6Q37645366-9F1A99DA-610E-40DE-8938-9C9E8AF5F784Q38062029-B39BA1E1-76EA-4E3B-BE5E-B3163A363EEAQ38284074-B502C6E5-480A-4DC7-9588-C1FC97827D92Q40293033-BC156DCA-F04C-4599-B2A6-F0FA8EB9679AQ41994105-B5C397BB-2D6B-42D5-9896-30787890015CQ42699604-8E99315E-15E3-4594-9362-4B87AF71AA8DQ48022505-842CCB9C-3410-4F0E-8973-596254B8BB13
P2860
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@ast
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@en
type
label
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@ast
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@en
prefLabel
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@ast
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@en
P2093
P2860
P356
P1476
A novel chimeric Plasmodium vi ...... h VK210 and VK247 sporozoites.
@en
P2093
Anjali Yadava
Christian F Ockenhouse
Hong Zheng
Lisa A Ware
Michael A Washington
Sanjai Kumar
Victoria Majam
P2860
P304
P356
10.1128/IAI.01667-06
P407
P577
2006-12-11T00:00:00Z